Go to page content

Sulphonylureas

Sulphonylureas are older-generation diabetes drugs. They formulaically stimulate the secretion of insulin from the pancreas.

Sulphonylureas are used to manage type 2 diabetes in adults as a phase two or three medicine together with lifestyle management and metformin or other blood sugar-lowering medicines or basal insulin. They can also be used on their own, if metformin or other blood sugar-lowering medicines are not suitable.

In Finland, the use of sulphonylureas tablets has become significantly less common, with new pharmaceutical products becoming available. In Finland (3/2026), only one sulfonylurea preparation is available on the market under special authorisation: glibenclamide.